CVS Health Corp (CVS) Shares Sold by ZWJ Investment Counsel Inc.
ZWJ Investment Counsel Inc. trimmed its stake in shares of CVS Health Corp (NYSE:CVS) by 1.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 295,102 shares of the pharmacy operator’s stock after selling 5,422 shares during the quarter. CVS Health makes up 1.9% of ZWJ Investment Counsel Inc.’s portfolio, making the stock its 16th biggest position. ZWJ Investment Counsel Inc. owned 290.29% of CVS Health worth $23,998,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Triangle Securities Wealth Management lifted its position in shares of CVS Health by 3.3% in the 2nd quarter. Triangle Securities Wealth Management now owns 28,208 shares of the pharmacy operator’s stock worth $2,270,000 after buying an additional 895 shares during the last quarter. Hefty Wealth Partners lifted its position in shares of CVS Health by 1,437.7% in the 2nd quarter. Hefty Wealth Partners now owns 14,793 shares of the pharmacy operator’s stock worth $1,190,000 after buying an additional 13,831 shares during the last quarter. First PREMIER Bank lifted its position in shares of CVS Health by 776.4% in the 2nd quarter. First PREMIER Bank now owns 9,334 shares of the pharmacy operator’s stock worth $751,000 after buying an additional 8,269 shares during the last quarter. Pioneer Trust Bank N A OR lifted its position in shares of CVS Health by 12.0% in the 2nd quarter. Pioneer Trust Bank N A OR now owns 17,350 shares of the pharmacy operator’s stock worth $1,396,000 after buying an additional 1,860 shares during the last quarter. Finally, Catawba Capital Management VA lifted its position in shares of CVS Health by 1.9% in the 2nd quarter. Catawba Capital Management VA now owns 121,235 shares of the pharmacy operator’s stock worth $9,755,000 after buying an additional 2,302 shares during the last quarter. Hedge funds and other institutional investors own 81.62% of the company’s stock.
A number of research analysts have recently issued reports on the stock. Royal Bank of Canada assumed coverage on shares of CVS Health in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target on the stock. Jefferies Group raised their price target on shares of CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a research report on Friday, September 15th. Leerink Swann raised their price target on shares of CVS Health from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Monday. Oppenheimer restated a “buy” rating and issued a $95.00 price target on shares of CVS Health in a research report on Monday, October 9th. Finally, Mizuho set a $90.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a report on Tuesday, October 24th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $86.66.
CVS Health Corp (NYSE:CVS) opened at $79.02 on Friday. The company has a market cap of $80,050.00, a PE ratio of 16.33, a price-to-earnings-growth ratio of 1.38 and a beta of 0.90. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. CVS Health Corp has a 52 week low of $66.45 and a 52 week high of $84.72.
CVS Health (NYSE:CVS) last released its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. CVS Health’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the company earned $1.64 EPS. equities research analysts forecast that CVS Health Corp will post 5.9 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.53%. CVS Health’s payout ratio is 41.32%.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the firm’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the transaction, the executive vice president now owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.61% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: “CVS Health Corp (CVS) Shares Sold by ZWJ Investment Counsel Inc.” was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.dailypolitical.com/2018/01/12/cvs-health-corp-cvs-shares-sold-by-zwj-investment-counsel-inc.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.